Medical/Pharmaceuticals
New Study Demonstrates Significantly Increased Healing Rates with NATROX® Oxygen Wound Therapy
Treatment offers hope for patients with long-standing chronic wounds CAMBRIDGE, England, July 12, 2021 /PRNewswire/ -- Inotec AMD, manufacturer of NATROX® Oxygen Wound Therapy, is delighted to share newly published randomised controlled trial (RCT) results[1]. The trial involved 145 patients with...
2021-07-12 13:00
1566
Everest Medicines Announces Strategic Commercial Partnership with Global Technology Company, Tencent
SHANGHAI, July 12, 2021 /PRNewswire/ -- Everest Medicines
2021-07-12 12:42
5541
LEAD Horizon: How Vienna gargles out of lockdown
VIENNA, July 12, 2021 /PRNewswire/ -- With the initiative "everything gargles" Vienna got through the pandemic better in comparison to other European cities. Every day, up to 70.000 people participate in the simple gargle PCR testing to inquire their Covid-19 status. Following the example ofVienn...
2021-07-12 08:30
2648
Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI323 (Anti-LAG-3/PD-L1 Bispecific Antibody) in Patients with Advanced Malignant Tumors
SAN FRANCISCO and SUZHOU, China, July 12, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-07-12 08:12
4878
Sciwind Biosciences Appoints Dr. Weidong Zhong as Chief Strategy Officer and President of its US Subsidiary
HANGZHOU, China and SAN FRANCISCO, July 12, 2021 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd., a clinical-stage, fast-growing biopharmaceutical company focusing on discovering and developing innovative therapies to treat chronic, metabolic and immunological diseases, announced today the...
2021-07-12 08:00
3672
Kintor Pharmaceutical Announced FDA Has Greenlighted Pyrilutamide's Phase II Clinical Trial for Androgenetic Alopecia in the US
SUZHOU, China, July 11, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has greenlighted pyrilutamide's phase...
2021-07-11 21:03
20233
HICOOL 2021 Global Entrepreneurship Competition (Preliminary Round) is Launched in Full Swing on July 10th
BEIJING, July 11, 2021 /PRNewswire/ -- On July 10th, HICOOL 2021 Global Entrepreneurship Competition (Qualifying Round) is launched in full swing. A total of 1,237 startups shortlisted for the preliminary round compete off-line inBeijing and online in a global context in six major industries: New...
2021-07-11 21:00
2201
Ortho Clinical Diagnostics' Quantitative COVID-19 IgG Antibody Test First to Receive FDA Emergency Use Authorization
- Ortho's new VITROS® Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which gives clinicians and public health leaders a standard tool to measure antibody response to SARS-CoV-2 - Ortho is ...
2021-07-10 03:33
30159
Clean interim safety review of RhoVac's clinical phase IIb study in prostate cancer
STOCKHOLM, July 9, 2021 /PRNewswire/ -- RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announces today onJuly 9th 2021, that its Safety Monitoring Committee has conducted a planned interim safety review of its clinical phase IIb trial in prostate cancer, known as BRaVac. The safety...
2021-07-09 21:38
3415
ABL Bio Announces Publication of Preclinical Data Demonstrating Safety and Efficacy of ABL503/TJ-L14B, a Novel Anti-PD-L1 X 4-1BB Bispecific Antibody
* ABL503/TJ-L14B demonstrates stronger anti-tumor efficacy than anti-PD-L1 or anti-4-1BB monotherapy as well as a good safety profile * ABL503 currently in Phase 1 trial to evaluate the safety, tolerability, MTD PK and PD in patients with advanced or metastatic solid tumors SEONGNAM, South Ko...
2021-07-09 21:00
3545
I-Mab Expands Emerging Portfolio of Next Generation Novel Oncology Therapeutics Through Cutting-Edge mRNA and AI Technology Platforms
SHANGHAI and GAITHERSBURG, Md., July 9, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced the signing of two new collaborations with emerging biote...
2021-07-09 20:00
30372
Alzheimer's Disease Researchers Release Free Memory Tracking App
SAN DIEGO, July 9, 2021 /PRNewswire/ -- Today, Leucadia Therapeutics Inc, a California HealthTech Company, is launching 8 Apps that help exercise memory and cognition, including a personalized memory tracker called ProCogny (procogny.com). ProCogny allows users to play memory-intensive puzzles an...
2021-07-09 18:00
2386
Sequanta and Mission Bio announce strategic partnership
SHANGHAI, July 8, 2021 /PRNewswire/ -- Sequanta Technologies Co., Ltd. ("Sequanta") and Mission Bio. ("Mission Bio") are pleased to announce that they have entered into a strategic partnership, providing high-quality single-cell sequence services using Mission Bio's products to customers in mainl...
2021-07-09 15:44
2180
Innovent Announces NMPA Acceptance of New Drug Application for the FGFR1/2/3 Inhibitor (Pemigatinib) for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement
SAN FRANCISCO, and SUZHOU, China, July 9, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-07-09 08:00
23643
Vaniam Group LLC announces European and International expansion with addition of new global agency, Vaniam Group Global Ltd
Dr. Louise Verrall appointed to lead Vaniam Group Global Ltd as Head of Europe & International CHICAGO, July 9, 2021 /PRNewswire/ -- Vaniam Group LLC today announced the establishment of Vaniam Group Global Ltd, expanding the company's strategic healthcare communications network footprint intoEu...
2021-07-09 06:50
2308
New Research Highlights Need for Health-Systems Approach to Vision Care
Study in The Gambia underscores success of local approach and policymaking. DALLAS, July 9, 2021 /PRNewswire/ -- A recent study of OneSight Vision Centers in TheGambia offers new insight into the importance of implementing a strengthening program for services that address poor vision through a he...
2021-07-09 03:14
2540
Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment of Solid Tumors Through the Precision Delivery of Alpha Radiation
JERUSALEM and WILMINGTON, Del., July 8, 2021 /PRNewswire/ -- Alpha Tau Medical Limited ("Alpha Tau"), the developer of the pioneering alpha-radiation cancer therapy Alpha DaRT™, and Healthcare Capital Corp. ("HCC") (Nasdaq: HCCC), a special purpose acquisition company, today announced they have e...
2021-07-08 21:13
31401
Yushangmei seeks to establish partnership with a new target company
GUANGZHOU, China, July 8, 2021 /PRNewswire/ -- Guangzhou Yushangmei Health Management Co., Ltd. announced the termination of the partnership with the company headquartered inNevada, USA. Meanwhile, Yushangmei has sought to establish partnership with a new target company, specific details will be ...
2021-07-08 19:29
4338
COVID pandemic heightens a lack of confidence amongst the public about which medicines to take and how to use them
New campaign, Let's treat it right, launches as online searches for self-care surge globally[1], as people take more responsibility for their everyday health. NYON, Switzerland, July 8, 2021 /PRNewswire/ -- Today sees the launch of Let's treat it right, a major new health education campaign d...
2021-07-08 16:00
1848
Nippon Express (India) Newly Acquires GDP Certification at Three Locations
TOKYO, July 8, 2021 /PRNewswire/ -- Nippon Express (India) Private Limited (hereinafter "NE India"), a local subsidiary of Nippon Express Co., Ltd., obtained Good Distribution Practice (GDP) certification in April for its temperature-controlled hubs inDelhi, Mumbai and Ahmedabad, evidencing the ...
2021-07-08 15:00
1390
Week's Top Stories
Most Reposted
Edufrienz 99: One of Asia's First Digital Platform Advancing Character Education for Future-Ready, Compassionate Children
[Picked up by 315 media titles]
2026-01-23 11:03
UOB prices AUD2 billion in five-year senior unsecured notes
[Picked up by 305 media titles]
2026-01-23 09:00AVPN's AI Opportunity Fund Expands Regional Efforts to Build AI Skilling Infrastructure for a Future-Ready Workforce Across Asia-Pacific
[Picked up by 302 media titles]
2026-01-21 12:39Government of Telangana and Blaize Sign MoU at Davos to Launch Telangana AI Innovation Hub and Advance Applied AI Initiatives
[Picked up by 297 media titles]
2026-01-22 15:16
Klook's study of 374,000 reviews finds that lesser-known cities create deeper emotional connection with travelers
[Picked up by 280 media titles]
2026-01-20 15:40
Most Read
Building the Run: Xtep Charts a New Community Ecosystem in Southeast Asia
2026-01-20 17:49
5428
